Less is more: Maintenance minimization as a step toward tolerance

American Journal of Transplantation

Volumn 3, Issue 6, 2003, Pages 643-645

  Kirk, Allan D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; STEROID;

ANTIGEN RECOGNITION; APOPTOSIS; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LONG TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MONOTHERAPY; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; REVIEW; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0037869416     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00138.x     Document Type: Review

References (12)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States 1988-96. N Engl J Med 2000; 342: 605-612.
2. Gourishankar S, Halloran PF. Late deterioration of organ transplants, a problem in injury and homeostasis. Curr Opin Immunol 2002; 14: 576-583.
3. Knechtle SJ, Pirsch JD, Fechner Jr JH et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003; 3: 722-730.
4. Kirk AD. Transplant tolerance: a look at the non-human primate literature in the view of modern tolerance theories. Crit Rev Immunol 1999; 19: 349-388.
5. Baldwin WM 3rd, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001; 14: 369-376.
6. Li XC, Strom TB, Turka LA, Wells AD. T cell death and transplantation tolerance. Immunity 2001; 14: 407-416.
7. Knechtle SJ, Vargo D, Fechner J et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997; 63: 1-6.
8. Calne R, Friend P, Moffatt S et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701-1702.
9. Swanson SJ, Hale DA, Mannon RB et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002; 360: 1662-1664.
10. Kirk AD, Swanson SJ, Mannon RB et al. Preliminary results from a human tolerance trial using Campath-1H. Am J Transplant 2001; 1: S136.
11. Waldmann H. Transplantation tolerance-where do we stand? Nat Med 1999; 5: 1245-1248.
12. Kirk AD, Harlan DM. Challenges for the clinical application of transplant tolerance strategies. Curr Opin Organ Transplant 2000; 5: 108-113.